G Morgan Selected Research

G Morgan Research Topics

Disease

12	Multiple Myeloma 03/2016 - 04/2000
9	Neoplasms (Cancer) 01/2016 - 01/2000
3	Infections 08/2004 - 03/2000
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016 - 04/2000
2	Breast Neoplasms (Breast Cancer) 04/2009 - 03/2008
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2008 - 12/2001
2	Hodgkin Disease (Hodgkin's Disease) 03/2008 - 04/2000
2	Hemorrhage 01/2008 - 01/2000
2	Muscle Weakness 10/2001 - 10/2001
2	Muscular Dystrophies (Muscular Dystrophy) 10/2001 - 10/2001
1	Paraproteinemias (Monoclonal Gammopathy) 03/2016
1	Toxic Optic Neuropathy 01/2016
1	Renal Insufficiency (Renal Failure) 02/2014
1	Radiculopathy (Radiculopathy, Cervical) 04/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2010
1	Venous Thromboembolism 08/2010
1	Amyloidosis 02/2009
1	Lymphoma (Lymphomas) 08/2008
1	Exfoliative Dermatitis (Erythroderma) 07/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2008
1	Eosinophilia 07/2008
1	Reinfection 07/2008
1	Second Primary Neoplasms (Neoplasms, Second) 03/2008
1	Carcinogenesis 01/2008
1	Congenital Heart Defects (Congenital Heart Defect) 12/2007
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2006
1	Paramyxoviridae Infections (Parainfluenza) 08/2006
1	Birth Weight (Birth Weights) 08/2005
1	Rhinitis 04/2005
1	Malnutrition (Nutritional Deficiencies) 09/2002
1	Hypersensitivity (Allergy) 09/2002
1	Starvation 09/2002
1	Poliomyelitis (Polio) 03/2002
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 10/2001
1	Rheumatoid Arthritis 10/2001
1	Polymyositis 06/2001
1	Stiff-Person Syndrome (Stiff Man Syndrome) 06/2001
1	Leukemia 03/2001
1	Neoplasm Metastasis (Metastasis) 02/2001
1	Pain (Aches) 02/2001

Drug/Important Bio-Agent (IBA)

4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2012 - 01/2000
2	Immunoglobulins (Immunoglobulin)IBA 03/2016 - 08/2015
2	Bortezomib (Velcade)FDA Link 04/2012 - 01/2012
2	Thalidomide (Thalomid)FDA Link 04/2012 - 08/2010
2	SalicylatesIBA 01/2010 - 01/2008
2	VaccinesIBA 09/2002 - 03/2002
2	Laminin (Merosin)IBA 10/2001 - 10/2001
1	KW-2478IBA 01/2016
1	Retinaldehyde (Retinal)IBA 01/2016
1	Bendamustine Hydrochloride FDA Link 02/2014
1	Cisplatin (Platino)FDA LinkGeneric 04/2012
1	Proteins (Proteins, Gene)FDA Link 04/2012
1	Vinca AlkaloidsIBA 04/2012
1	Immunomodulating AgentsIBA 01/2012
1	Prednisone (Sone)FDA LinkGeneric 08/2010
1	Melphalan (Alkeran)FDA LinkGeneric 08/2010
1	ProstaglandinsIBA 01/2010
1	plerixafor FDA Link 10/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2009
1	Lenalidomide (CC 5013)FDA Link 04/2009
1	Blood Proteins (Serum Proteins)IBA 02/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 08/2008
1	Gemcitabine FDA Link 08/2008
1	Topotecan (Hycamtin)FDA LinkGeneric 08/2008
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 08/2008
1	Immunoglobulin A (IgA)IBA 07/2008
1	Immunoglobulin E (IgE)IBA 07/2008
1	Immunoglobulin G (IgG)IBA 07/2008
1	Immunoglobulin M (IgM)IBA 07/2008
1	InterferonsIBA 08/2007
1	Interferon-alpha2bIBA 08/2007
1	Carbon MonoxideIBA 08/2005
1	Nitrogen DioxideIBA 08/2005
1	Environmental Pollutants (Pollutants, Environmental)IBA 08/2005
1	Particulate MatterIBA 08/2005
1	AllergensIBA 04/2005
1	SugarsIBA 09/2002
1	LeptinIBA 09/2002
1	CytokinesIBA 09/2002
1	Secretory Immunoglobulin A (SIgA)IBA 09/2002
1	Hormones (Hormone)IBA 09/2002
1	Neutralizing AntibodiesIBA 03/2002
1	AntigensIBA 03/2002
1	Janus Kinase 3IBA 12/2001
1	AntibodiesIBA 10/2001
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2001
1	Glycine Receptors (Glycine Receptor)IBA 06/2001
1	DNA (Deoxyribonucleic Acid)IBA 03/2001
1	quinone (benzoquinone)IBA 03/2001
1	NAD (NADH)IBA 03/2001
1	QuinonesIBA 03/2001
1	Oxidoreductases (Dehydrogenase)IBA 03/2001

Therapy/Procedure

11	Therapeutics 01/2016 - 04/2000
6	Drug Therapy (Chemotherapy) 10/2009 - 04/2000
5	Stem Cell Transplantation 10/2009 - 04/2000
4	Radiotherapy 04/2009 - 02/2001
2	Chemoprevention 01/2008 - 01/2000
1	Autologous Transplantation 07/2008
1	Maintenance Chemotherapy 07/2008
1	Hospital to Home Transition 12/2007